| Financial Year |
March 31 2023 |
| Monetary Funds |
127,350,950.55 |
| Held-for-trading Financial Assets |
120,282,051.37 |
| Notes Receivable |
-- |
| Accounts Receivable |
481,661,643.81 |
| Advances to Suppliers |
52,361,887.99 |
| Other Receivables |
53,521,282.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
351,853,458.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
54,593,263.91 |
| Other Current Assets |
17,315,730.00 |
| Total Current Assets |
1,315,457,167.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,473,835.43 |
| Investment Properties |
12,057,376.35 |
| Fixed Assetes |
118,565,404.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,212,997.83 |
| R&D expenses |
9,584,949.50 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
64,654.10 |
| Deferred Income Tax Assets |
9,703,428.05 |
| Other Non-Current Assets |
48,921,440.00 |
| Sub-Total of Non-Current Assets |
230,504,299.61 |
| Total Assets |
1,545,961,467.59 |
| Short-Term Loans |
39,837,360.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
45,964,539.26 |
| Accounts Payable |
188,350,430.36 |
| Accounts Received In Advance |
334,805.40 |
| Employee Compensation Payable |
21,079,679.31 |
| Taxes Payable |
17,534,164.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
76,919,659.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,271,390.40 |
| Other Current Liabilities |
6,385,011.72 |
| Sub-Total of Current Liabilities |
454,000,598.66 |
| Long-term Loans |
14,214,827.14 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,623,254.84 |
| Deferred Income Tax Liabilities |
272,387.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,776,181.68 |
| Total Liabilities |
480,776,780.34 |
| Paid-In Capital(Or Share Stock) |
346,009,804.00 |
| Capital Surplus |
356,944,851.70 |
| Surplus Reserve |
230,621,965.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
58,853,629.05 |
| Minority Stockholder's Interest |
68,830,075.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
996,354,611.34 |
| Owner's Equity（Stockholder's Equity） |
1,065,184,687.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,545,961,467.59 |
